Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer
Clinical Breast Cancer · 2024-06 · 24 (4) · e279-e288
DOI: 10.1016/j.clbc.2024.01.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024-06. Verfasst von Nurgül Orhan Metin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beytepe Murat Erdi Eker State Hospital, Radiology Unit, Ankara, Turkey. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Tomography, X-Ray Computed, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: To investigate the correlation between quantitative parameters obtained by dual energy spectral computed tomography (DESCT) and various histopathological factors and biomarkers associated with the prognosis of breast cancer. MATERIALS AND METHODS: Quantitative parameters such as iodine content (IC), normalized IC (nIC), iodine enhancement (IE) and normalized IE (nIE) were measured on virtual monochromatic images and iodine mapping images obtained from DESCT in 116 female breast cancer patients. The relationship between these parameters and prognostic biomarkers such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status and Ki67 levels, as well as the correlation with histological grade (HG), lymphovascular invasion (LVI), and metastatic axillary lymphadenopathy (LAP) were evaluated. RESULTS: ER-negative tumors had significantly higher values of IC, nIC, IE, and nIE compared to ER-positive tumors. PR-negative tumors had significantly higher values of IE and nIEc compared to PR-positive tumors. HER2 overexpressed and Ki-67 high proliferation tumors showed significantly higher values of all quantitative parameters compared to HER2 negative and Ki-67 low proliferation tumors. All quantitative parameters were significantly higher in HG 3 tumors, tumors with detected LVI, and tumors with metastatic axillary LAP compared to low-grade tumors, LVI-negative tumors and tumors without metastatic axillary lymph nodes, respectively. CONCLUSION: Quantitative parameters of IC and IE obtained from DESCT have shown potential for predicting prognosis in breast cancer patients. Higher values of these parameters have been found to correlate with poor prognostic biomarkers and histopathological features. These results suggest that quantitative DESCT imaging may offer an additional benefit in the noninvasive prediction of breast cancer prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beytepe Murat Erdi Eker State Hospital, Radiology Unit, Ankara, Turkey.
- Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Radiology, Ankara University Faculty of Medicine, Ankara, Turkey. Electronic address: ymetin53@gmail.com.
- Department of Radiology, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.
- Ankara Sincan District Health Directorate, Ankara, Turkey.
Zitieren
APA
Metin, N. O., Balcı, S., Metin, Y., Taşçı, F., & Gözükara, M. G. (2024). Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer. Clinical Breast Cancer, 24(4), e279-e288. https://doi.org/10.1016/j.clbc.2024.01.022
Vancouver
Metin NO, Balcı S, Metin Y, Taşçı F, Gözükara MG. Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer. Clinical Breast Cancer. 2024;24(4):e279-e288. doi:10.1016/j.clbc.2024.01.022
BibTeX
@article{Metin2024,
author = {Metin, Nurgül Orhan and Balcı, Sinan and Metin, Yavuz and Taşçı, Filiz and Gözükara, Melih Gaffar},
title = {Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer},
journal = {Clinical Breast Cancer},
year = {2024},
volume = {24},
number = {4},
pages = {e279--e288},
doi = {10.1016/j.clbc.2024.01.022}
}
EUVIMED